SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Radiopharm Theranostics announces $4.1M registered direct offering and up to A$12.7M Australian financing

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.